Published in Cancer Law Weekly, January 13th, 2007
The study was undertaken by Dr. Jorge Cortes, Dr. Hagop Kantarjian and colleagues from the M.D. Anderson Cancer Center in Houston, Texas and data were presented in a poster at the American Society of Hematology (ASH) Annual Meeting held in Orlando, Florida. The presentation described the effects of the Ceflatonin and Gleevec combination therapy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.